Experts are joining us at ESMO 2025 to share their views on new data on GU, lung, breast, gynecological and upper GI cancers
PRRT and emerging strategies in neuroendocrine tumours
Early treatment intensification with a PARPi plus ARPI combination
Expert insights on the latest data in oncogene-addicted non-small cell lung cancer
Two perspectives, one aim: A pathologist and a medical oncologist in discussion
Learn about the evolving treatment landscape and best practices